A Ernest Toth Jr is SVP, Chief Financial Officer of Aquestive Therapeutics, Inc.. Currently has a direct ownership of 248,295 shares of AQST, which is worth approximately $893,862. The most recent transaction as insider was on Mar 09, 2024, when has been sold 11,705 shares (Common Stock) at a price of $4.88 per share, resulting in proceeds of $57,120. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 248K
0% 3M change
77.35% 12M change
Total Value Held $893,862

A ERNEST TOTH Jr Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 09 2024
SELL
Payment of exercise price or tax liability
$57,120 $4.88 p/Share
11,705 Reduced 4.5%
248,295 Common Stock
Mar 07 2024
BUY
Grant, award, or other acquisition
-
120,000 Added 31.58%
260,000 Common Stock
Mar 09 2023
BUY
Grant, award, or other acquisition
-
140,000 Added 50.0%
140,000 Common Stock
AET

A Ernest Toth Jr

SVP, Chief Financial Officer
Warren, NJ

Track Institutional and Insider Activities on AQST

Follow Aquestive Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AQST shares.

Notify only if

Insider Trading

Get notified when an Aquestive Therapeutics, Inc. insider buys or sells AQST shares.

Notify only if

News

Receive news related to Aquestive Therapeutics, Inc.

Track Activities on AQST